New Promises of Chemical Proteomics for Drug Development

Massimiliano Gaetani and Roman A Zubarev
Additional contact information
Roman A Zubarev: Department of Medical Biochemistry and Biophysics, Karolinska Institute, Sweden

Novel Approaches in Drug Designing & Development, 2017, vol. 2, issue 1, 12-14

Abstract: The road to development of a new drug often begins with the idea of its target protein, which could result from evidence emerging from different research sources, including academia, clinics and industry. However, taking a single compound to the drug market involves a very high cost, often over a billion of US dollars, and requires on average a time commitment between ten and fifteen years. The entire process is very complicated and, even in the lucky cases when the final development steps are reached, it sometimes collapses because of a failure related to the drug target, which is its starting point. Indeed, one of the major reasons of drug failures in clinical trials is the lack of efficacy due to low specificity of the drug towards the desired target. Sometimes, when the promising candidate compound is found in a large-scale phenotypic screening, the target is not even known a priori.

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555579.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555579.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:2:y:2017:i:1:p:12-14

DOI: 10.19080/NAPDD.2017.02.555579

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().